Clinical Trials Logo

Clinical Trial Summary

This study aims to compare whether a combination of two drugs (Mifepristone and misoprostol) are superior compared to using only one of these drugs (Misoprostol) as medical treatment for a miscarriage. Women in whom early pregnancy failure, 6-14 weeks postmenstrual, is ultrasonographically confirmed qualify for this study.

It is expected that the combination of Mifepristone and Misoprostol is more effective in reaching complete evacuation, and therefore can prevent more invasive treatment such as curettage.


Clinical Trial Description

This study will test the hypothesis that, in early pregnancy failure, the sequential combination of mifepristone with misoprostol is superior to the use of misoprostol alone in terms of complete evacuation of products of conception (primary outcome), patient satisfaction, complications, side effects and costs (secondary outcomes). The trial will be performed multi-centred (hospitals), prospectively, two-armed, randomized, double-blinded and placebo-controlled.

Women with ultrasonographically confirmed early pregnancy failure (6-14 weeks postmenstrual), managed expectantly for at least one week, can be included. Before medical treatment with misoprostol (two doses 400mcg (four hours apart), repeated after 24 hours if no tissue is lost), patients will be randomized to oral mifepristone (600mg) or oral placebo (identical in appearance). The investigators aim to randomize 460 women in a 1:1 ratio, stratified by centre.

After six weeks, the primary endpoint, complete or incomplete evacuation, will be determined ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03212352
Study type Interventional
Source Radboud University
Contact
Status Terminated
Phase Phase 4
Start date June 27, 2018
Completion date March 16, 2020

See also
  Status Clinical Trial Phase
Completed NCT03178682 - Ultrasound Predictors of Early Pregnancy Failure in Patients With Recurrent Pregnancy Loss N/A
Terminated NCT00468299 - MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure N/A
Completed NCT00782860 - Early Pregnancy Failure: Factors Affecting Successful Medical Termination Treatment N/A